Treatment Innovation & Treatment Technology
Treatment technology is at the heart of fundamental restructuring of the health and human service system, particularly in sectors serving consumers with the most complex needs. Tech-enabled treatment has the potential to improve clinical decision making and consumer outcomes, as well as reduce unnecessary administrative burdens. Historically, the health and human service system does not have a great executive bench for understanding and assessing the plethora of new technology options—leaving the “science to service” gap larger than ever. However, as payers look for innovative approaches that go beyond traditional forms of treatment, provider organizations must step up to the challenge and leverage new technologies and virtual delivery systems that engage and empower consumers.
Editor’s Picks
-
HHS Seeks To Accelerate AI Use For Health Care
-
Primary Care Digital Platform For Behavioral Health Decreased PMPM Spend
-
FDA Seeks Statements Of Interest For TEMPO Digital Health Devices Pilot For Those With Chronic Disease
-
Hospitals Offering Digital Remote Patient Monitoring Services Up 40% In Five Years
Latest Resources
- Federal Policy Meets Clinical Innovation: A Conversation With ASTP/ONC
- Navigating The Next Chapter Of Substance Use Disorder – Policy, Pressure, Clinical Reality & Organization Strategy: A Discussion With Denny Morrison, PhD, Chief Clinical Officer of Eleos Health
- Microsoft Launches New Copilot Health AI Assistant
- Mave Health Raises $2.1 Million To Launch Consumer Brain Stimulation Headset
- Chronilogix Announces Safety-Focused AI Platform For Mental Health & Chronic Care Coaching
- Mantra Health Launches Beacon Platform To Support Student Well-Being & Retention
- Enterprise Ireland & Northwell Health Expand Strategic Alliance To Support U.S. Market Entry
- In Structured Test, ChatGPT Health Undertriaged 52% Of Emergency Cases, Often Advising Delayed Care
- Consumer AI Chatbot Therapists Failed To Meet Counseling Ethics Standards, With 15 Types Of Ethical Risks Identified
- Patient Care America Launches KidneyLyfe, A Digital Community For People Living With Kidney Disease
- Fullscript & ĹŚURA Partner To Integrate Wearable Data Into Clinical Workflows, Adding Personalized Assessment To Whole Person Care
- Personalized Antidepressant Treatment Reduced Discontinuation In Major Depressive Disorder (17% vs. 27%)
- Crisis & Re-Stabilization Emergency Services (CARES) By Spectrum Health & Human Services: An OPEN MINDS Program Profile
- Five-Day Accelerated rTMS As Effective As Six Weeks Of Standard Treatment For Depression
- Neurolief Receives FDA PMA Approval For At-Home Neuromodulation Therapy For Treatment-Resistant Depression
To sign-up for monthly Treatment Innovation & Treatment Technology alerts, you must be signed in to your account.
Latest Industry Bulletins
- Enterprise Ireland & Northwell Health Expand Strategic Alliance To Support U.S. Market Entry
- Microsoft Launches New Copilot Health AI Assistant
- Mave Health Raises $2.1 Million To Launch Consumer Brain Stimulation Headset
- Chronilogix Announces Safety-Focused AI Platform For Mental Health & Chronic Care Coaching
Latest Industry News
- In Structured Test, ChatGPT Health Undertriaged 52% Of Emergency Cases, Often Advising Delayed Care
- Consumer AI Chatbot Therapists Failed To Meet Counseling Ethics Standards, With 15 Types Of Ethical Risks Identified
- Personalized Antidepressant Treatment Reduced Discontinuation In Major Depressive Disorder (17% vs. 27%)
- Five-Day Accelerated rTMS As Effective As Six Weeks Of Standard Treatment For Depression
- Mobile Medical Units For Homeless Veterans Increase Primary Care, Case Management Use
